Photoactivatable Fluorescent Tags for Dual-Modality Positron Emission Tomography Optical Imaging

J Med Chem. 2022 Jan 13;65(1):811-823. doi: 10.1021/acs.jmedchem.1c01899. Epub 2022 Jan 4.

Abstract

Fluorescent protein conjugates are vital tools in a wide range of scientific disciplines from basic biochemical research to applications in clinical pathology and intraoperative surgery. We report the synthesis and characterization of photoactivatable fluorophores (PhotoTags) based on the functionalization of coumarin, fluorescein, BODIPY, rhodamine B, and cyanine dyes with a photochemically active aryl azide group. Photochemical labeling experiments using human serum albumin produced fluorescent proteins in high yields under irradiation with ultraviolet light for <15 min. We also synthesized DFO-RhodB-PEG3-ArN3─a photoactivatable compound that can be radiolabeled with 89Zr for applications in optical imaging and positron emission tomography. One-pot 89Zr-radiolabeling and light-induced protein conjugation produced [89Zr]ZrDFO-RhodB-PEG3-azepin-trastuzumab. Proof-of-concept studies in vitro and in vivo confirmed that [89Zr]ZrDFO-RhodB-PEG3-azepin-trastuzumab is a potential dual-modality agent for detecting human epidermal growth factor receptor 2 (HER2/neu) expression. Overall, the PhotoTag technology represents a rapid, synthetically versatile, and user-friendly approach for generating novel protein conjugates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Azides / chemistry
  • Female
  • Fluorescent Dyes / chemical synthesis*
  • Fluorescent Dyes / pharmacokinetics
  • Humans
  • Light
  • Mice
  • Mice, Nude
  • Photochemical Processes
  • Positron-Emission Tomography / methods*
  • Radioisotopes
  • Receptor, ErbB-2 / drug effects
  • Serum Albumin
  • Tissue Distribution
  • Trastuzumab / chemistry
  • Ultraviolet Rays
  • Zirconium

Substances

  • Azides
  • Fluorescent Dyes
  • Radioisotopes
  • Serum Albumin
  • Zirconium
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab